Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing Ticagrelor and Clopidogrel in Acute Ischemic Stroke or Transient Ischemic Attack
IRCT20130311012781N6Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ticagrelor and clopidogrel in ischemic stroke and transient ischaemic attack (TIA) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Feb 2024; status: completed.
02
Drugs
ticagrelorclopidogrel
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on IRCT20130311012781N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130311012781N6.